Modulation of Kv1.5 channel expression and function by the sigma 1 receptor

被引:0
|
作者
Zambrano, Alba Vera [1 ]
Rinne, Susanne [2 ]
Baena-Nuevo, Maria [1 ]
Morales-Cano, Daniel [3 ]
Barreira, Bianca [4 ]
Decher, Niels
Cogolludo, Angel
Gallego, Teresa Gonzalez [1 ]
机构
[1] Univ Autonoma Madrid, Biochem, Madrid, Spain
[2] Philipps Univ Marburg, Inst Physiol & Pathophysiol, Marburg, Germany
[3] Ctr Nacl Invest Cardiovasc, Madrid, Spain
[4] Univ Complutense Madrid, Pharmacol & Toxicol, Madrid, Spain
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
1894-Pos
引用
收藏
页码:390A / 391A
页数:2
相关论文
共 50 条
  • [21] The Potassium Channel Kv1.5 Expression Alters During Experimental Autoimmune Encephalomyelitis
    I. Bozic
    D. Savic
    A. Milosevic
    M. Janjic
    D. Laketa
    K. Tesovic
    I. Bjelobaba
    M. Jakovljevic
    N. Nedeljkovic
    S. Pekovic
    I. Lavrnja
    Neurochemical Research, 2019, 44 : 2733 - 2745
  • [22] Drug Discoveries Towards Kv1.5 Potassium Channel
    Yang, Qian
    Wang, Xiaojian
    Du, Lupei
    Li, Minyong
    You, Qidong
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (04) : 339 - 347
  • [23] Open channel block of Kv1.5 currents by citalopram
    Lee, Hyang Mi
    Hahn, Sang June
    Choi, Bok Hee
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (04) : 429 - 435
  • [24] Regulation of KV1.5 Channel Density in the Rat Atria
    Balse, Elise
    Barbier, Camille S. M.
    Eichel, Catherine A.
    Rucker-Martin, Catherine
    Boycott, Hannah E.
    Louault, Florent
    Coulombe, Alain
    Hatem, Stephane N.
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 740A - 740A
  • [25] Benzopyran sulfonamides as Kv1.5 potassium channel blockers
    Lloyd, John
    Atwal, Karnail S.
    Finlay, Heather J.
    Nyman, Michael
    Huynh, Tram
    Bhandaru, Rao
    Kover, Alexander
    Schmidt, Joan
    Vaccaro, Wayne
    Conder, Mary Lee
    Jenkins-West, Tonya
    Levesque, Paul
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3271 - 3275
  • [26] Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias
    Brendel, J
    Peukert, S
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (11) : 1589 - 1598
  • [27] Evidence for proteasomal degradation of Kv1.5 channel protein
    Kato, M
    Ogura, K
    Miake, J
    Sasaki, N
    Taniguchi, SI
    Igawa, O
    Yoshida, A
    Hoshikawa, Y
    Murata, M
    Nanba, E
    Kurata, Y
    Kawata, Y
    Ninomiya, H
    Morisaki, T
    Kitakaze, M
    Hisatome, I
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 337 (01) : 343 - 348
  • [28] Pharmacophore Mapping for Kv1.5 Potassium Channel Blockers
    Yang, Qian
    Du, Lupei
    Tsai, Keng-Chang
    Wang, Xiaojian
    Li, Minyong
    You, Qidong
    QSAR & COMBINATORIAL SCIENCE, 2009, 28 (01): : 59 - 71
  • [29] Proteolytic cleavage in the S1-S2 linker of the Kv1.5 channel does not affect channel function
    Hogan-Cann, Andrew
    Li, Wentao
    Guo, Jun
    Yang, Tonghua
    Zhang, Shetuan
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2016, 1858 (06): : 1082 - 1090
  • [30] Biophysical Properties and Molecular Determinants Kv1.5 Channel Block By A Novel Kv1.5 Blocker Against Atrial Fibrillation
    Liao, Yu-Hua
    Du, Yi-Mei
    Zhang, Xiao-Xian
    Tu, Dan-Na
    Zhao, Ning
    Liu, Yan-Jie
    Xiao, Hua
    Zou, An-Ruo
    Sanguinetti, Michael C.
    CIRCULATION, 2010, 122 (02) : E216 - E216